Insights & Publications

Pharmaceuticals & Medical Products

Novartis on digitizing medicine in an aging world
interview

Novartis on digitizing medicine in an aging world

June 2015—CEO Joseph Jimenez explains where the company is placing its bets and how it’s seeking to bridge biology with technology.more

  • includes:
    •  

Editor's choice

Africa_pharma_1536x1536_Thumbnail
article

Africa: A continent of opportunity for pharma and patients

June 2015—Africa may be the only pharmaceutical market where genuinely high growth is still achievable. Here’s what’s driving that strength and how companies should react.more

Maintaining_momentum_in_Brazils_pharma_market_1536_Thumbnail
article

Maintaining momentum in Brazil’s pharmaceutical market

April 2015—Despite macroeconomic deceleration, we expect Brazil's pharma market to grow 7–10 percent per year until 2020. Double-digit growth is possible, but will require a granular approach.more

Japan_hyperagingV2_1536x1536_New_Thumbnail
article | McKinsey Quarterly

Japan: Lessons from a hyperaging society

March 2015—The country’s population, already the world’s oldest, is aging quickly. Companies in Europe, North America, and Asia can learn from its experience.more

Capturing the new value segment_1536x1536_Thumbnail
article

Capturing the new ‘value’ segment in medical devices

January 2015—The growing demand for products that are “good enough” and competitively priced has pushed medical-product manufacturers to develop strategies to attract and retain this new segment of customers.more

Medical-device manufacturers_1536x1536_Thumbnail
article

How medical-device manufacturers can transform marketing and sales capabilities

January 2015—Device manufacturers experiencing declining growth or narrowing margins may need to reevaluate their commercial models.more

IandP_Rapid-growth-in-biopharma_1536x1536_Thumbnail
article

Rapid growth in biopharma: Challenges and opportunities

December 2014—Biopharmaceuticals could become the core of the pharmaceutical industry, but not without significant transformation in the laboratory and in strategy, technology, and operations.more

A-digital-prescription_1536x1536_Thumbnail
article

A digital prescription for pharma companies

November 2014—Pharmaceutical and medical-device companies have been slow to adopt digitization. Here are five reasons they should get moving. more

Value_creation_1536x1536_Thumbnail
article

Value creation in medical device M&A

September 2014—Successful large, transformative deals are rare in medical devices. With further consolidation ahead, future acquirers need to reconsider their approach in the context of a programmatic M&A strategy.more

Pharma_1536x1536_Thumbnail
article | McKinsey Quarterly

Confronting change fatigue in the pharmaceutical industry

September 2014—A decade of restructuring and transformation efforts has taken a toll on organizational health.more

Horwood_1536x1536_Thumbnail
commentary

Developing a global digital strategy

October 2014—How does a global company take advantage of digital technology? Johnson & Johnson’s vice president of digital strategy, Gail Horwood, explains.more

  • includes:
    •  
Pharma_launches_1536x1536_Thumbnail
article

Pharma’s first-to-market advantage

September 2014—What’s the value of bringing a drug to market first? In some cases, it may be less than you think.more

Healthcares-digital-future_1536x1536_Thumbnail
article

Healthcare’s digital future

July 2014—Insights from our international survey can help healthcare organizations plan their next moves in the journey toward full digitization.more

About this content

The material on this page draws on the research and experience of McKinsey consultants and other sources. To learn more about our expertise, please visit the Pharmaceuticals & Medical Products Practice.